1Neaton JD, Blackburn H. Serumcholesterol levd and mortality findings for men screened in the multiple risk factor intervention trial: multiple risk faetou intervention trial research group[J]. Arch Intern Med, 1992, 152(8):1490-1500.
2Du Clos TW. Function of C-reactive protein[J]. Ann Med, 2000, 32 (4) :274-248.
3Koh KK, Quon MJ, Hart SH, et al. Additive beneficial effects losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients [ J ]. Circulation, 2004, 110 (24) : 3687-3692.
4Koh KK, Quon MJ, Han SH, et al. Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients ruth combined hyperlipidemia[ J]. J Am Coll Cardiol ,2005, 45(6): 1649-1653.
5Li JJ, Fang CH, C-reactive protein is not only an inflammatory marker but also a dilect cause of cardiovascular disease[ J]. Med Hypoth, 2004, 62(3) :499.
6Mohrscmadt MF, Weverling-Rijsbuxger AW, de Man FH, et al. Hypertriglyceridemia affects cytokine production in whale blood samples ex vivo. The influence of lipid-lowering therapy[J]. Atherosclerosis, 2000,148(2) :413.
